ArticleClinical immunology (Orlando, Fla.)2020

mTORC inhibitor Sirolimus deprograms monocytes in "cytokine storm" in SARS-CoV2 secondary hemophagocytic lymphohistiocytosis- like syndrome.

Claudio Karsulovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.